Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.590
+0.040 (1.13%)
At close: Jun 26, 2026, 4:00 PM EDT
3.630
+0.040 (1.11%)
After-hours: Jun 26, 2026, 6:42 PM EDT
Voyager Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Voyager Therapeutics stock have an average target of 16, with a low estimate of 8.00 and a high estimate of 25. The average target predicts an increase of 345.68% from the current stock price of 3.59.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Voyager Therapeutics stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 11 | 11 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +596.38% | Jun 25, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 18, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $22 | Buy | Maintains | $22 | +512.81% | Jun 2, 2026 |
| Wedbush | Wedbush | Buy Maintains $8 | Buy | Maintains | $8 | +122.84% | May 18, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $12 | Buy | Reiterates | $12 | +234.26% | May 11, 2026 |
Financial Forecast
Revenue This Year
43.53M
from 40.37M
Increased by 7.82%
Revenue Next Year
61.69M
from 43.53M
Increased by 41.71%
EPS This Year
-1.58
from -2.04
EPS Next Year
-1.58
from -1.58
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 125.7M | 122.9M | |
| Avg | 43.5M | 61.7M | |
| Low | 9.0M | 20.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 211.2% | 182.4% | |
| Avg | 7.8% | 41.7% | |
| Low | -77.7% | -54.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.71 | -0.53 | |
| Avg | -1.58 | -1.58 | |
| Low | -1.96 | -2.59 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.